Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.55 |
| ▸ | STAT3 | P40763 | 13/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425998 | 0.92 | ELANE (0.46) | ELANESTAT3MEN1MAPTKMT2A | |
| Asperulosidic Acid SCHEMBL422107 | 0.90 | MAPT (0.52) | ELANESTAT3MEN1MAPTKMT2A | |
| Asperulosidic Acid SCHEMBL29459346 | 0.90 | MAPT (0.52) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29425847 | 0.90 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL28912673 | 0.90 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29425898 | 0.89 | ELANE (0.65) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL20572206 | 0.89 | ELANE (0.65) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29896779 | 0.89 | ELANE (0.65) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29425927 | 0.89 | ELANE (0.65) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL29425804 | 0.86 | STAT3 (0.56) | ELANESTAT3MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102846784-B | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO., LTD. (CN) | 2014-10-01 | — | — | CN | claimed |
| CN-102846784-A | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2013-01-02 | — | — | CN | claimed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | claimed |
| EP-4702037-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224085-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| CN-115308331-A | Method for determining content of 5 components in standard oldenlandia diffusa decoction freeze-dried powder or formula granules by adopting one-test-multiple evaluation method | 山东宏济堂制药集团股份有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-114994206-A | Method for detecting quality of standard hedyotis diffusa decoction | 湖南新汇制药股份有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-102846784-B | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO., LTD. (CN) | 2014-10-01 | — | — | CN | disclosed |
| CN-102846784-A | Paederia scandens water extract, and preparation method and application thereof | NINGBO DACHANG PHARMACEUTICAL CO LTD | 2013-01-02 | — | — | CN | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
| US-4410710-A | Conversion of iridoids to prostaglandins | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 1983-10-18 | — | — | US | disclosed |